M. Krailo

发表

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

S. Donaldson, N. Tarbell, M. Link, 2003, The New England journal of medicine.

Randomized comparison of every-two-week v. every-three-week chemotherapy in Ewing sarcoma family tumors (ESFT)

D. West, M. Krailo, P. Dickman, 2008 .

Cancer in adolescents and young adults

G. Reaman, L. Zeltzer, M. Krailo, 1993, Cancer.

Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors.

C. Rodríguez-Galindo, A. L. Frazier, D. Gershenson, 2014, The oncologist.

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: A report from the Children’s Oncology Group

John H. Healey, E. Kleinerman, J. Healey, 2008 .

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Paul A Meyers, Mark D Krailo, E. Kleinerman, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.

A. Huvos, M. Krailo, J. Miser, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial.

W. H. Kern, S. Groshen, J. Sakamoto, 1991, The Journal of urology.

Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).

G. Reaman, J. Reid, M. Ames, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study.

S. Baruchel, L. Lau, D. Malkin, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Childhood cancer patients' access to cooperative group cancer programs

Leslie Bernstein, L. Bernstein, G. Reaman, 2003, Cancer.

Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group.

James R. Anderson, G. Reaman, M. O'Leary, 2008, Seminars in oncology.

Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: A report from the Children's Oncology Group

M. Georgieff, G. Tomlinson, J. Ross, 2014, Pediatric Blood & Cancer.

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

C. Lau, T. Man, M. Krailo, 2016, Cancer research.

Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group.

G. Reaman, J. Reid, M. Ames, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Maternal pregnancy events and exposures and risk of hepatoblastoma: a Children's Oncology Group (COG) study.

M. Georgieff, G. Tomlinson, J. Ross, 2013, Cancer epidemiology.

Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology Group.

G. Tomlinson, J. Ross, J. Feusner, 2012, Human reproduction.

Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report.

G. Reaman, R. Slack, M. Cairo, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study.

Helen X. Chen, S. Baruchel, R. Kerbel, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333.

T. Zhou, J. Biegel, T. Merchant, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.

C. Rodríguez-Galindo, A. L. Frazier, J. Amatruda, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Children's Oncology Group's 2013 blueprint for research: Rare tumors

C. Rodríguez-Galindo, M. Chintagumpala, G. Tomlinson, 2013, Pediatric blood & cancer.

A Phase I study of concurrent RMP‐7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas

M. Mehta, G. Reaman, R. Packer, 2005 .

Age at natural menopause and breast cancer risk: the effect of errors in recall.

M. Pike, A. Paganini-Hill, M. Krailo, 1984, American journal of epidemiology.

Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.

J. Reid, M. Ames, J. Kuttesch, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BREAST CANCER IN YOUNG WOMEN AND USE OF ORAL CONTRACEPTIVES: POSSIBLE MODIFYING EFFECT OF FORMULATION AND AGE AT USE

M. Pike, B. Henderson, M. Krailo, 1983, The Lancet.

Update of the Los Angeles Study of oral contraceptives and breast cancer: 1981 and 1983.

L. Bernstein, M. Krailo, Pike Mc, 1990 .

Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium

C. Rodríguez-Galindo, A. L. Frazier, J. Amatruda, 2020, Cancer.

Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans.

A. Pappo, C. Rodríguez-Galindo, Zhengjia Chen, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study.

J. Dancey, P. Adamson, M. Bernstein, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of carboplatin in children with acute leukemia in bone marrow relapse: A report from the childrens cancer group

P. Gaynon, M. Krailo, L. Ettinger, 1993, Cancer.

A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: A Children's Oncology Group study

P. Adamson, Zhengjia Chen, C. Stewart, 2010, Pediatric blood & cancer.

Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors

P. Adamson, S. Spunt, L. McGregor, 2009, Cancer.

Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma.

H. Katzenstein, M. Krailo, E. McGahren, 2007, Journal of pediatric surgery.

Estimation of the distribution of age at natural menopause from prevalence data.

M. Pike, M. Krailo, 1983, American journal of epidemiology.

Phase 2 Trial of the GPNMB-Targeted Antibody-Drug Conjugate, Glembatumumab Vedotin (CDX-011) in Recurrent Osteosarcoma AOST1521: A Report from the Children’s Oncology Group (COG)

R. Randall, J. Reid, A. Buxton, 2020 .

Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group

Helen X. Chen, P. Adamson, J. Reid, 2014, Pediatric blood & cancer.

A Phase I/IB trial of murine monoclonal anti‐GD2 antibody 14.G2a plus interleukin‐2 in children with refractory neuroblastoma

K. Matthay, R. Seeger, G. Reaman, 1997, Cancer.

A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children's Oncology Group

K. Matthay, P. Adamson, R. Seeger, 2006, Clinical Cancer Research.

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study.

K. Matthay, R. Seeger, G. Reaman, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression profiling of Ewing sarcoma tumours reveals the prognostic importance of tumour–stromal interactions: a report from the Children's Oncology Group

T. Triche, U. Dirksen, E. Lawlor, 2015, The journal of pathology. Clinical research.

Childhood Acute Leukemia1

S. Siegel, M. Krailo, J. Finklestein, 2006 .

Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.

G. Reid, Zhengjia Chen, Kevin She, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Developing and Using a Data Commons for Understanding the Molecular Characteristics of Germ Cell Tumors.

A. L. Frazier, ShinYi Lin, B. Ci, 2021, Methods in molecular biology.

Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group.

P. Adamson, J. Reid, M. Ames, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Imatinib mesylate ( STI 571 ) for treatment of children with Philadelphia chromosome – positive leukemia : results from a Children ’ s Oncology Group phase 1 study

M. Bernstein, R. Capdeville, B. Peng, 2004 .

Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group.

B. Crompton, R. Randall, Alice Yu, 2022, European journal of cancer.

Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.

Yukichi Tanaka, T. Hishiki, R. Alaggio, 2017, The Lancet. Oncology.

Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.

G. Cuvelier, Zhengjia Chen, A. Kariminia, 2008, Blood.

The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research.

I. Tannock, M. Stockler, M. Buyse, 2021, The Lancet. Oncology.

Family history of cancer in children and adolescents with germ cell tumours: a report from the Children’s Oncology Group

A. L. Frazier, J. Amatruda, M. Krailo, 2017, British Journal of Cancer.

Patterns of enrollment on cooperative group studies. An analysis of trends from the Los Angeles county cancer surveillance program

L. Bernstein, J. Sullivan‐Halley, M. Krailo, 1993, Cancer.

Trends in patterns of treatment of childhood cancer in los angeles county

L. Bernstein, J. Sullivan‐Halley, M. Krailo, 1993, Cancer.

Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma—Associations with tumor phenotype and survival

Jason U Tilan, Hongkun Wang, J. Toretsky, 2015, Cancer.

Parental occupational exposure to pesticides and childhood germ-cell tumors.

X. Shu, P. Stewart, L. Robison, 2005, American journal of epidemiology.

Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431.

M. Krailo, E. Orgel, L. Sung, 2022, The Lancet. Oncology.

Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group.

K. Matthay, R. Seeger, G. Reaman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.

M. Ladanyi, R. Gerbing, C. Herzog, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

F. Askin, L. Robison, S. Bhatia, 2007, Blood.

A summary of the osteosarcoma banking efforts: A report from the Children's Oncology Group and the QuadW Foundation

T. Fan, C. Khanna, K. Janeway, 2015, Pediatric blood & cancer.

Outcomes for patients with congenital hepatoblastoma

D. V. von Schweinitz, G. Tomlinson, J. Feusner, 2013, Pediatric blood & cancer.

Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: A report from the Children's Oncology Group

P. Leavey, N. Tarbell, M. Gebhardt, 2008, Pediatric blood & cancer.

Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.

J. Kurtzberg, M. Devidas, J. Whitlock, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of surgery in abdominal non-Hodgkin's lymphoma: experience from the Childrens Cancer Study Group.

C. Stolar, M. LaQuaglia, S. Siegel, 1992, Journal of pediatric surgery.

Ovarian Yolk Sac Tumors; Does Age Matter?

Caihong Xia, Furqan Shaikh, Brice Fresneau, 2017, International Journal of Gynecologic Cancer.

Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children’s Oncology Group.

S. Lessnick, E. Lawlor, H. Grier, 2015 .

BREAST CANCER IN YOUNG WOMEN AND USE OF ORAL CONTRACEPTIVES: POSSIBLE MODIFYING EFFECT OF FORMULATION AND AGE AT USE

M. Pike, B. Henderson, M. Krailo, 1983, The Lancet.

Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women.

M. Pike, B. Henderson, A. Paganini-Hill, 1984, Cancer research.

Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma

M. Sydes, S. Bielack, A. Wiener, 2022, European journal of cancer.

Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321)

T. Merchant, C. Rodríguez-Galindo, M. Chintagumpala, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcoma.

F. Sim, J. Neglia, D. Hawkins, 2009, The Journal of bone and joint surgery. American volume.

Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015).

K. Neville, P. Adamson, M. Bernstein, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment†

K. S. Hall, L. Trani, M. Sydes, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Eﬀ ects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial

B. Pollock, K. Knight, E. Neuwelt, 2016 .

Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial.

P. Adamson, F. Balis, G. Reaman, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): A Children's Oncology Group Report

A. Angiolillo, J. Whitlock, Zhengjia Chen, 2006, Pediatric blood & cancer.

Adjuvant chemotherapy following cystectomy benefits patients with deeply invasive bladder cancer.

S. Groshen, S. Boyd, C. Russell, 1990, Seminars in urology.

Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group.

J. Whitlock, P. Steinherz, J. Reid, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Reply to G. Mangili et al and C. Lhommé et al.

C. Rodríguez-Galindo, A. L. Frazier, M. Krailo, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of treatment of malignant germ cell tumors in 93 children: a report from the Childrens Cancer Study Group.

M. Krailo, N. Ramsay, J. Grosfeld, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chromosome abnormalities of eighty‐one pediatric germ cell tumors: Sex‐, age‐, site‐, and histopathology‐related differences—a Children's Cancer Group study

K. Bussey, D. Arthur, S. Olson, 1999, Genes, chromosomes & cancer.

Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study.

M. Borowitz, P. Adamson, J. Reid, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I Study of 90Yttrium-Ibritumomab-Tiuxetan in Children and Adolescents with Relapsed/Refractory CD20-Positive Non–Hodgkin's Lymphoma: A Children's Oncology Group Study

S. Perkins, A. Angiolillo, P. Adamson, 2007, Clinical Cancer Research.

Clinical and function of polymorphic GGAA-microsatellites in Ewing sarcoma: a report from the Children's Group.

L. Jorde, W. Watkins, J. Schiffman, 2014 .

Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: a Childrens Cancer Study Group report.

J. Reid, M. Ames, M. Krailo, 1990, Cancer research.

Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: A Children's Oncology Group report

P. Adamson, G. Reaman, J. Franklin, 2008, Pediatric blood & cancer.

Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.

J. Quinn, J. Feusner, M. Krailo, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.

J. Cullen, R. Giller, M. Krailo, 1999, American journal of obstetrics and gynecology.

Biochemical pharmacology of high dose 1-beta-D-arabinofuranosylcytosine in childhood acute leukemia.

M. Krailo, J. Finklestein, L. Ettinger, 1987, Cancer research.

Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: A report from the Children's Oncology Group

E. Conrad, D. Hawkins, P. Meyers, 2011, Pediatric blood & cancer.

High-Dose M elphalan, E toposide, T otal-Body I rradiation, and A utologous S tem-Cell R econstitution a s C onsolidation Therapy f or H igh-Risk E wing's S arcoma D oes N ot Improve P rognosis

M. Ladanyi, R. Gerbing, C. Herzog, 2001 .

Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report.

P. Houghton, P. Adamson, J. Wright, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A comparison of imaging, clinical, and pathologic aspects of space-occupying lesions within the brain in patients with acquired immune deficiency syndrome.

A. Levine, M. Krailo, W. Boswell, 1986, American journal of physiologic imaging.

A Phase I Trial of Immunocytokine HU14.18-IL2 in Children with Recurrent or Refractory Neuroblastoma and Other GD2 Positive Malignancies: A Study of the Children's Oncology Group

K. Matthay, P. Adamson, R. Seeger, 2004 .

Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children’s Oncology Group

B. Crompton, K. Stegmaier, A. Thorner, 2022, British Journal of Cancer.

Analysis of local control outcomes and clinical prognostic factors in localized pelvic Ewing sarcoma patients treated with radiation therapy: A Report from the Children's Oncology Group.

W. Harmsen, R. Randall, P. Rose, 2022, International journal of radiation oncology, biology, physics.

Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group

S. Lessnick, E. Lawlor, H. Grier, 2015, Pediatric blood & cancer.

Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.

C. Rodríguez-Galindo, G. Tiao, S. Ranganathan, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children's Oncology Group.

A. L. Frazier, A. Bagrodia, N. Singla, 2022, Journal of pediatric urology.

A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: A report from the Childrens Cancer Study Group

K. Ruccione, N. Ru, W. Krivit, 1990, Journal of Neuro-Oncology.

Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group.

W. Harmsen, R. Randall, K. Janeway, 2017, International journal of radiation oncology, biology, physics.

Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.

P. Adamson, F. Balis, G. Reaman, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow

P. Gaynon, M. Krailo, L. Ettinger, 1997, Cancer.

Clinical trial enrollment of adolescents and young adults with sarcoma

D. Reinke, G. Schwartz, R. Randall, 2017, Cancer.

Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion.

F. Balis, G. Reaman, J. Reid, 1993, Cancer research.

Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study

A. Pappo, C. Rodríguez-Galindo, A. L. Frazier, 2018, Pediatric blood & cancer.

Phase I/II study of bisantrene in childhood cancer: a report from the Childrens Cancer Study Group.

W. Krivit, M. Krailo, G. Hammond, 1988, Medical and pediatric oncology.

Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia.

S. Feig, T. Tjoa, B. Lange, 2000, The cancer journal from Scientific American.

Phase I Study of Gemcitabine (Difluorodeoxycytidine) in Children with Relapsed or Refractory Leukemia (CCG-0955): A Report from the Children's Cancer Group

G. Reaman, P. Steinherz, J. Reid, 2002, Leukemia & lymphoma.

Treatment of childhood nasopharyngeal carcinoma (cNPC) with neoadjuvant chemotherapy (NAC) and concomitant chemoradiotherapy (CCRT): Results of the Childrens Oncology Group ARAR0331 study.

A. Pappo, C. Rodríguez-Galindo, M. Krailo, 2016 .

Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group.

G. Reaman, M. Krailo, V. Avramis, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Do regular ovulatory cycles increase breast cancer risk?

M. Pike, B. Henderson, R. Ross, 1985, Cancer.

Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study.

M. Bernstein, R. Capdeville, B. Peng, 2004, Blood.

‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer

D. G. Hoel, M. C. Pike, J. T. Casagrande, 1983, Nature.

Phase I study of CI‐958 in children and adolescents with recurrent solid tumors

G. Reaman, C. Arndt, M. Krailo, 2001, Cancer.

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.

B. Pollock, K. Knight, E. Neuwelt, 2017, The Lancet. Oncology.

Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin

M. Krailo, P. Prete, M. Bułanowski, 1994, Clinical Rheumatology.

A. Levine, M. Krailo, M. Rarick, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial.

J. McCutchan, B. Parker, E. Muchmore, 1991, The American journal of medicine.

The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention.

B. Henderson, L. Bernstein, R. Ross, 1987, British Journal of Cancer.

Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group

C. Shields, J. O'Brien, B. Langholz, 2017, Pediatric blood & cancer.

Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.

J. O'Brien, K. Matthay, M. Ali, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of pulmonary metastases of initial stage. I. Hepatoblastoma in childhood. Report from the childrens cancer group

J. Feusner, D. Lloyd, M. Krailo, 1993, Cancer.

Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.

C. Weldon, C. Rodríguez-Galindo, G. Tiao, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pulmonary Kaposi's sarcoma: clinical findings and results of therapy.

P. Colletti, A. Levine, M. Krailo, 1989, The American journal of medicine.

Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group.

L. Constine, P. Davis, R. Hutchinson, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders

R. Burkes, M. Krailo, R. Carmel, 1987, European journal of haematology.

The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882).

C. Stolar, P. Colombani, J. Cullen, 2001, Journal of pediatric surgery.

Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.

R. Sposto, P. Steinherz, S. Siegel, 2001, Medical and pediatric oncology.

Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study.

C. Stolar, J. Cullen, R. Giller, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study

C. Rodríguez-Galindo, A. L. Frazier, J. Cullen, 2018, Pediatric blood & cancer.

Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII).

M. Krailo, S. Stoneham, J. Nicholson, 2019, European journal of cancer.

Klinefelter syndrome in males with germ cell tumors: A report from the Children's Oncology Group

Lindsay A. Williams, A. L. Frazier, N. Pankratz, 2018, Cancer.

Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative

C. Rodríguez-Galindo, A. L. Frazier, D. Gershenson, 2016, Cancer.

Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology group

C. Lau, A. L. Frazier, N. Pankratz, 2017, Genes, chromosomes & cancer.

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma

E. Kleinerman, J. Healey, E. Conrad, 2009, Cancer.

Fibrolamellar hepatocellular carcinoma in children and adolescents

J. Quinn, E. Douglass, M. Sensel, 2003, Cancer.

Germ cell tumors in infancy and childhood: a 45-year experience.

M. Krailo, J. Ortega, G. Mahour, 1990, Pediatric pathology.

Immature teratomas: identification of patients at risk for malignant recurrence.

S. Siegel, M. Krailo, J. Ortega, 1989, Journal of the National Cancer Institute.

Expression of LINE-1 p40 protein in pediatric malignant germ cell tumors and its association with clinicopathological parameters: a report from the Children's Oncology Group.

X. Shu, Q. Cai, L. Robison, 2007, Cancer letters.

Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium.

C. Rodríguez-Galindo, A. L. Frazier, J. Amatruda, 2018, European journal of cancer.

Is Adjuvant Chemotherapy necessary in Ovarian Immature Teratoma? A Combined Data Analysis from The Malignant Germ Cell Tumors International Collaborative (MaGIC)

C. Rodríguez-Galindo, A. L. Frazier, D. Gershenson, 2015 .

Parental Tobacco and Alcohol Use and Risk of Hepatoblastoma in Offspring: A Report from the Children's Oncology Group

Kimberly J. Johnson, G. Tomlinson, J. Ross, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group.

H. Katzenstein, M. Finegold, M. Krailo, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.

J. Quinn, E. Douglass, M. Sensel, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma

K. Muczynski, M. Krailo, T. Vietti, 1989, Cancer.

α‐Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium

C. Rodríguez-Galindo, A. L. Frazier, J. Amatruda, 2019, Cancer.

Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?

C. Rodríguez-Galindo, A. L. Frazier, D. Gershenson, 2018, Gynecologic oncology.

Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: A children's oncology group study

D. Neuberg, D. Finkelstein, P. Adamson, 2010, Pediatric blood & cancer.

Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

J. Healey, D. West, J. Dormans, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.

P. Leavey, J. Healey, M. Devidas, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study.

A. Pappo, C. Rodríguez-Galindo, M. Krailo, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of intermediate‐dose cytarabine in patients with relapsed or refractory Ewing sarcoma: A report from the Children's Oncology Group

K. Stegmaier, S. Lessnick, Richard D. Smith, 2009, Pediatric blood & cancer.

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors

H. Friedman, M. Bernstein, G. Reaman, 2007, Cancer.

Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation

M. Krailo, N. Treister, H. Dang, 2016, British Journal of Cancer.

Rare Tumors in Children: Progress Through Collaboration.

A. Ferrari, A. Pappo, L. Helman, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients.

G. Reaman, M. Krailo, L. Ettinger, 1990, Cancer research.

Phase 1/2 Trial of Vorinostat and Radiation and Maintenance Vorinostat in Children with Diffuse Intrinsic Pontine Glioma: A Children's Oncology Group Report.

P. Adamson, A. Buxton, A. Gajjar, 2021, Neuro-oncology.

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

M. Sydes, P. Leavey, R. Goldsby, 2019, European journal of cancer.

A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)

D. Teachey, P. Houghton, R. Lock, 2019, Clinical Cancer Research.

Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study.

Soma Das, P. Adamson, Zhengjia Chen, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group

B. Widemann, N. Jayaprakash, M. Krailo, 2015, Pediatric blood & cancer.

Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study.

Mark D Krailo, Marta Hamilton, J. Dancey, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

K. S. Hall, M. Sydes, P. Leavey, 2016, The Lancet. Oncology.

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

E. Kleinerman, A. Huvos, J. Healey, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group

R. Goldsby, K. Janeway, R. Gorlick, 2018, Pediatric blood & cancer.

Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy—a report from the Children's Oncology Group

Chris L. Fryer, R. Goldsby, S. Donaldson, 2007, Pediatric blood & cancer.

Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.

S. Donaldson, N. Tarbell, M. Link, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

E. V. Van Allen, G. Ha, B. Crompton, 2018, British Journal of Cancer.

Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children's Oncology Group (COG) study.

S. Savage, C. Sklar, K. Silverstein, 2012, International journal of molecular epidemiology and genetics.

Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children’s Oncology Group

W. Woods, J. Neglia, Zhengjia Chen, 2015, Journal of immunotherapy.

Phase I Study of B43-PAP Immunotoxin in Combination with Standard 4-Drug Induction for Patients with CD 19+ Acute Lymphoblastic Leukemia (ALL) in Relapse, A Children's Cancer Group Study

G. Reaman, F. Uckun, J. Franklin, 1999, Pediatric Research.

Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status

J. Greally, M. Fazzari, R. Gorlick, 2015, Epigenetics.

A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis.

Michelle M. Nuño, A. L. Frazier, N. Coleman, 2021, Clinical genitourinary cancer.

The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database

Yukichi Tanaka, T. Hishiki, R. Alaggio, 2020, Pediatric blood & cancer.

Ewing Tumors That Do Not Overexpress BMI-1 Are a Distinct Molecular Subclass with Variant Biology: A Report from the Children's Oncology Group

Aaron R Cooper, M. Ladanyi, Dafydd G. Thomas, 2010, Clinical Cancer Research.

Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.

T. Triche, S. Lessnick, H. Shimada, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human Cancer Biology Ewing Tumors That Do Not Overexpress BMI-1 Are a Distinct Molecular Subclass with Variant Biology : A Report from the Children ' s Oncology Group

Aaron R Cooper, M. Ladanyi, Dafydd G. Thomas, 2010 .

Burkitt's and Burkitt‐like lymphoma in children and adolescents: a review of the Children's Cancer Group Experience *

James R. Anderson, W. Sanger, S. Perkins, 2003, British journal of haematology.

HER‐2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study

R. Randall, M. Bernstein, K. Janeway, 2014, Pediatric blood & cancer.

MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.

D. Reardon, P. Davis, M. Trigg, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TR-14A FEASIBILITY AND RANDOMIZED PHASE II STUDY OF VORINOSTAT, BEVACIZUMAB, OR TEMOZOLOMIDE DURING RADIATION FOLLOWED BY MAINTENANCE CHEMOTHERAPY IN NEWLY-DIAGNOSED PEDIATRIC HIGH-GRADE GLIOMA: CHILDREN'S ONCOLOGY GROUP STUDY ACNS0822

I. Pollack, D. Boue, D. Haas-Kogan, 2015 .

Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate (‘Orange’) in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a Children's Cancer Group Report

M. Cairo, M. Krailo, R. Harris, 2002, Leukemia.

Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.

J. Quinn, J. Feusner, M. Krailo, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.

C. Rodríguez-Galindo, A. L. Frazier, J. Cullen, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group

E. Kleinerman, D. Hawkins, M. Bernstein, 2010, Clinical Cancer Research.

Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.

R. Goldsby, R. Randall, M. Bernstein, 2013, European journal of cancer.

Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children’s Oncology Group

Lindsay A. Williams, H. Nelson, A. L. Frazier, 2018, British Journal of Cancer.

Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors

A. Jimeno, M. Hidalgo, P. Adamson, 2007, Pediatric blood & cancer.

Results of initial lymph node biopsy in homosexual men with generalized lymphadenopathy.

J. Parker, A. Levine, R. Burkes, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retrovirus and malignant lymphoma in homosexual men.

J. Parker, A. Levine, R. Burkes, 1985, JAMA.

Serum beta‐2 microglobulin levels in homosexual men with aids and with persistent, generalized lymphadenopathy

A. Sherrod, A. Levine, R. Burkes, 1986, Cancer.

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group.

P. Gaynon, N. Ru, M. Krailo, 1994, Cancer.

Special considerations in the design and implementation of pediatric otoprotection trials

K. Knight, M. Krailo, E. Orgel, 2023, Journal of Cancer Survivorship.

Prevention of cisplatin‐induced hearing loss in children: Informing the design of future clinical trials

L. Minasian, B. Pollock, A. L. Frazier, 2018, Cancer medicine.

Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma

P. Meltzer, J. Trent, E. Kleinerman, 2014, Clinical Cancer Research.

Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis.

W. Akerley, M. Krailo, S. Grunberg, 1986, Cancer investigation.

Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.

M. Krailo, S. Grunberg, K. Johnson, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†.

C. Lau, M. Chintagumpala, R. Packer, 2015, Neuro-oncology.

Abstracts reprinted from Journal of Clinical Oncology

J. Quinn, E. Douglass, M. Sensel, 2002, Annals of Surgical Oncology.

ATRT-04. CORRELATION OF CLINICOPATHOLOGIC FEATURES AND CUMULATIVE INCIDENCE OF RELAPSE FOR PATIENTS WITH ATYPICAL TERATOID RHABDOID TUMOR ON ACNS0333: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP

J. Biegel, A. Huang, A. Judkins, 2021, Neuro-Oncology.

Phase II Trial of Ixabepilone Administered Daily for Five Days in Children and Young Adults with Refractory Solid Tumors: A Report from the Children's Oncology Group

P. Adamson, F. Balis, B. Widemann, 2010, Clinical Cancer Research.

Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results.

S. Formenti, J. Cohen, S. Rasheed, 1986, Annals of internal medicine.

Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group Study.

J. Whitlock, G. Reaman, J. Reid, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall: Impact of Initial Versus Delayed Resection on Tumor Margins, Survival, and Use of Radiation Therapy

N. Tarbell, M. Devidas, M. Gebhardt, 2003, Annals of surgery.

Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group

K. Janeway, R. Gorlick, P. Meyers, 2018, Pediatric blood & cancer.

Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group.

S. Feig, B. Lange, M. Krailo, 1998, Journal of Clinical Oncology.

Phase I/II study of idarubicin given with continuous infusion fludarabine followed by continuous infusion cytarabine in children with acute leukemia: a report from the Children's Cancer Group.

G. Reaman, M. Krailo, N. Seibel, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.

S. Grupp, B. Langholz, Zhengjia Chen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: A Children's Oncology Group study

P. Adamson, A. Pappo, M. Bernstein, 2008, Pediatric blood & cancer.

Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma

John Healey, J. Healey, Zhengjia Chen, 2007, Cancer.

Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors

Zhengjia Chen, J. Strain, G. Reaman, 2006, Cancer.

Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: The Children's Cancer Group (CCG) experience

A. Angiolillo, G. Reaman, M. Cairo, 2005, Pediatric blood & cancer.

The CCSG prospective study of venous access devices: an analysis of insertions and causes for removal.

J. Buckley, C. Stolar, E. Wiener, 1992, Journal of pediatric surgery.

Workgroup #4: Clinical research implications

L. Bernstein, Malcolm Smith, R. Ho, 1993 .

Rejoinder

L. McShane, Lingyun Ji, R. Sposto, 2019, Clinical trials.

Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial

L. McShane, Lingyun Ji, R. Sposto, 2019, Clinical trials.

Predictive power of pretreatment prognostic factors in children with hepatoblastoma: A report from the Children's Oncology Group

Zhengjia Chen, H. Katzenstein, M. Krailo, 2009, Pediatric blood & cancer.

Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group

B. Crompton, D. Rakheja, Helen X. Chen, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group.

R. Randall, J. Reid, A. Buxton, 2019, European journal of cancer.

Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.

A. Huvos, J. Bertino, J. Healey, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children’s Hepatic Tumors International Collaboration (CHIC)

Yukichi Tanaka, T. Hishiki, R. Alaggio, 2023, Cancers.

Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.

S. Grupp, A. Kariminia, J. Rozmus, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group Report

R. Randall, H. Grier, M. Krailo, 2015, Sarcoma.

The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.

T. Hishiki, I. Leuschner, D. V. von Schweinitz, 2016, European journal of cancer.

Amifostine does not prevent platinum‐induced hearing loss associated with the treatment of children with hepatoblastoma

A. Pappo, W. London, Zhengjia Chen, 2009, Cancer.

Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: a report from the Children's Cancer Study Group.

G. Reaman, M. Krailo, J. Finklestein, 1991, Cancer research.

A Phase I Clinical, Pharmacologic, and Biologic Study of Thrombopoietin and Granulocyte Colony-Stimulating Factor in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Recurrent or Refractory Solid Tumors: A Children's Oncology Group Experience

A. Angiolillo, G. Reaman, M. Cairo, 2005, Clinical Cancer Research.

A comparison of rhTPO and rhIL-11 following ifosfamide (I), carboplatin (C) and etoposide (E) (ICE) in pediatric patients with recurrent solid tumors or lymphoma.

A. Angiolillo, G. Reaman, M. Cairo, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional

G. Reaman, J. Reid, M. Ames, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.

U. Dirksen, A. Craft, R. Goldsby, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG‐782 and INT0133—A Report From the Children's Oncology Group Bone Tumor Committee

M. Gebhardt, L. Teot, K. Janeway, 2016, Pediatric blood & cancer.

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

M. Sydes, J. Gerss, R. Randall, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Congenital abnormalities and hepatoblastoma: A report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB)

M. Georgieff, J. Schiffman, K. Curtin, 2014, American journal of medical genetics. Part A.

Abstract 3774: Congenital abnormalities and hepatoblastoma: A report from the Children's Oncology Group (COG)

M. Georgieff, G. Tomlinson, J. Ross, 2010 .

Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol

C. Weldon, R. Ribeiro, A. Pappo, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.

B. Freidlin, P. Catalano, L. Rubinstein, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk of childhood germ cell tumors in association with parental smoking and drinking

X. Shu, L. Robison, S. Davies, 2005, Cancer.

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.

D. Brat, T. Zhou, M. Rosenblum, 2016, Neuro-oncology.

Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.

P. Steinherz, J. Kersey, M. Krailo, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicted leukocyte telomere length and risk of germ cell tumours

A. L. Frazier, N. Pankratz, A. J. Hooten, 2022, British Journal of Cancer.

Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group.

Zhengjia Chen, M. Bernstein, L. Teot, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical and Biochemical Function of Polymorphic NR0B1 GGAA-Microsatellites in Ewing Sarcoma: A Report from the Children's Oncology Group

L. Jorde, W. Watkins, J. Schiffman, 2014, PloS one.

Reply to S. Upadhyaya.

T. Zhou, I. Pollack, A. Judkins, 2020, Journal of Clinical Oncology.

Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial

A. Gajjar, A. Levy, M. Fouladi, 2021, Pediatric blood & cancer.

AT-09TREATMENT OF ATYPICAL TERATOID RHABDOID TUMORS (ATRT) OF THE CENTRAL NERVOUS SYSTEM WITH SURGERY, INTENSIVE CHEMOTHERAPY, AND 3-D CONFORMAL RADIATION (ACNS0333). A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP

J. Biegel, I. Pollack, A. Judkins, 2016 .

Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.

S. Donaldson, N. Tarbell, F. Laurie, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma : a report of the Children ’ s Oncology Group ACNS 0423 study

D. Brat, T. Zhou, M. Rosenblum, 2016 .

Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: A Children's Oncology Group trial (P9962)

P. Adamson, M. Krailo, S. Berg, 2012, Pediatric blood & cancer.

Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report

P. Leavey, R. Randall, D. Hawkins, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of Translocation Testing in Patients Enrolling to a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.

B. Crompton, D. Rakheja, S. Lessnick, 2021, Archives of pathology & laboratory medicine.

Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.

C. Rodríguez-Galindo, G. Tiao, S. Ranganathan, 2019, The Lancet. Oncology.

Development of a Data Model and Data Commons for Germ Cell Tumors.

Yang Xie, Donghan M Yang, Guanghua Xiao, 2020, JCO clinical cancer informatics.

Treatment of childhood adrenocortical carcinoma (ACC) with surgery plus retroperitoneal lymph node dissection (RPLND) and multiagent chemotherapy: Results of the Children’s Oncology Group ARAR0332 protocol.

C. Weldon, R. Ribeiro, A. Pappo, 2016 .

Anti-CD13 antibodies in children with extensive chronic graft-versus-host disease and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031

S. Grupp, S. Dunn, G. Cuvelier, 2010, Bone Marrow Transplantation.

Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.

Helen X. Chen, C. Ahern, P. Adamson, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study.

P. Bonate, N. Winick, M. Bernstein, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

International collaboration is feasible in trials for rare conditions: the EURAMOS experience.

M. Sydes, S. Bielack, M. Bernstein, 2007, Cancer treatment and research.

A pilot study of low‐dose anti‐angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893

S. Baruchel, D. Malkin, M. Bernstein, 2013, Pediatric blood & cancer.

Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the Children's Oncology Group AHEP 0731 Liver Tumor Committee.

C. Weldon, G. Tiao, S. Ranganathan, 2020, Journal of pediatric surgery.

Treatment of hepatoblastoma: the North American cooperative group experience.

H. Katzenstein, M. Krailo, M. Malogolowkin, 2012, Frontiers in bioscience.

13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group.

C. Reynolds, G. Blair, M. Krailo, 1992, Medical and pediatric oncology.

A phase II clinical trial of idarubicin administered to children with relapsed brain tumors

B. Scheithauer, G. Reaman, C. Arndt, 1998, Cancer.

Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.

W. London, Zhengjia Chen, K. Newman, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Upfront window vincristine/irinotecan treatment of high‐risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee

C. Rodríguez-Galindo, G. Tiao, S. Ranganathan, 2017, Cancer.

Redefining the role of doxorubicin for the treatment of children with hepatoblastoma.

Zhengjia Chen, J. Quinn, H. Katzenstein, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pediatrie Phase I Trial and Pharmacokinetic Study of Topotecan Administered as a 24-Hour Continuous Infusion 1

F. Balis, G. Reaman, J. Reid, 2006 .

Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study.

M. Mehta, T. Zhou, I. Pollack, 2008, Neuro-oncology.

A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952.

M. Mehta, J. Ater, M. Krailo, 2003, Neuro-oncology.

Inflammatory Markers and Autoantibodies That Correlate with Early and Late Onset of New Onset Pediatric Chronic Graft-Versus-Host Disease (GVHD).

Zhengjia Chen, Kevin She, M. Krailo, 2006 .

Topotecan by 21‐day continuous infusion in children with relapsed or refractory solid tumors: A Children's Oncology Group study

P. Adamson, D. Hawkins, J. Whitlock, 2006, Pediatric blood & cancer.

The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy.

J. Quinn, K. Newman, J. Feusner, 1991, Journal of pediatric surgery.

Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial.

F. Balis, G. Reaman, R. Hutchinson, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group

S. Steinberg, F. Balis, B. Widemann, 2006, Cancer Chemotherapy and Pharmacology.

Phase 1 study of concurrent RMP‐7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas

M. Mehta, G. Reaman, R. Packer, 2005, Cancer.

Phase I Trial of Cisplatin and Topotecan in Children With Recurrent Solid Tumors: Children's Cancer Group Study 0942

G. Reaman, J. Reid, M. Ames, 2002, Journal of pediatric hematology/oncology.

Topotecan, as a radiosensitizer, for brainstem glioma (BSG) of childhood: First report of CCG 0952, a phase i study

M. Mehta, R. Mosher, J. Ater, 1998 .

Identification of Discrete Prognostic Groups in Ewing Sarcoma

M. Segal, P. Meyers, H. Grier, 2016, Pediatric blood & cancer.

Event-free survival and overall survival in 2,253 patients with osteosarcoma registered to EURAMOS-1

K. S. Hall, M. Sydes, R. Randall, 2015 .

Outcome for adolescent and young adult patients with osteosarcoma

Paul A Meyers, Mark D Krailo, Richard Gorlick, 2012, Cancer.

Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: A report from the Children's Oncology Group

S. Lessnick, R. Randall, R. Gorlick, 2015, Pediatric blood & cancer.

Phase I Evaluation of Oral and Intravenous Vinorelbine in Pediatric Cancer Patients: A Report from the Children's Oncology Group

T. Madden, M. Ames, J. Kuttesch, 2006, Clinical Cancer Research.

Randomized comparison of antibiotics with and without granulocyte colony‐stimulating factor in children with chemotherapy‐induced febrile neutropenia: A report from the Children's Oncology Group

Zhengjia Chen, J. Feusner, M. Krailo, 2005, Pediatric blood & cancer.

High‐BMI at diagnosis is associated with inferior survival in patients with osteosarcoma: A report from the Children's Oncology Group

C. Arndt, P. Meyers, M. Krailo, 2013, Pediatric blood & cancer.

Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: A Children's Oncology Group study

A. Bleyer, T. Madden, J. Kuttesch, 2009, Pediatric blood & cancer.

Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection.

J. Healey, N. Tarbell, M. Gebhardt, 2000, The Journal of thoracic and cardiovascular surgery.

Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group

S. Donaldson, J. Healey, R. Randall, 2015, Cancer.

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group

S. Lipshultz, M. Bernstein, K. Janeway, 2019, Cardio-Oncology.

A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trials.

Mourad Tighiouart, Mark D Krailo, S. Azen, 2010, Contemporary clinical trials.

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.

D. Hawkins, B. Widemann, T. Zwerdling, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group

B. Crompton, A. Thorner, C. Cibulskis, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Doxorubicin in combination with cisplatin, 5‐flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study

C. Weldon, C. Rodríguez-Galindo, G. Tiao, 2021, Cancer.

Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group

Ha M Dang, D. Hawkins, M. Bernstein, 2021, Pediatric blood & cancer.

Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.

C. Rodríguez-Galindo, A. L. Frazier, J. Amatruda, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.

C. Rodríguez-Galindo, A. L. Frazier, J. Cullen, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of serum insulin growth factor‐1 concentrations in localized osteosarcoma: A children's oncology group study

J. Toretsky, M. Bernstein, A. Goorin, 2014, Pediatric blood & cancer.

Investigation of the insulin‐like growth factor‐1 signaling pathway in localized Ewing sarcoma

J. Toretsky, B. Kallakury, M. Krailo, 2011, Cancer.

Occupational Exposure to Pesticides and Childhood Germ-Cell Tumors

X. Shu, P. Stewart, L. Robison, 2005 .

Prospective Randomized Trial Between Two Doses of Granulocyte Colony-Stimulating Factor After Ifosfamide, Carboplatin, and Etoposide in Children With Recurrent or Refractory Solid Tumors: A Children's Cancer Group Report

G. Reaman, M. Cairo, B. Blazar, 2001, Journal of pediatric hematology/oncology.

In utero exposure to female hormones and germ cell tumors in children

X. Shu, H. Cai, L. Robison, 2006, Cancer.

An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Childrens Cancer Group (Canada, United States)

X. Shu, J. Buckley, L. Robison, 1995, Cancer Causes & Control.

Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency Syndrome

J. Parker, A. Levine, R. Burkes, 1987, Cancer.

The effect of compliance with treatment on survival among patients with hematologic malignancies.

A. Levine, J. Richardson, M. Krailo, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HEALTH RISKS OF LEAD AS JUDGED FROM AUTOPSY MATERIAL

M. Krailo, W. Cherry, Forbes Wf, 1981 .

Prognostic implications of blast cell morphology in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.

J. Lukens, S. Siegel, D. Hammond, 1985, Cancer treatment reports.

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group

S. Lipshultz, J. Healey, M. Devidas, 2016, Pediatric blood & cancer.

Fitting models of carcinogenesis to a case-control study of breast cancer.

M. Pike, D. Thomas, M. Krailo, 1987, Journal of chronic diseases.

Can Big Data Shed Light on the Origins of Pediatric Cancer?

A. L. Frazier, M. Krailo, J. Poynter, 2016, Pediatrics.

Use of unequal allocation in survival trials.

R. Sposto, M. Krailo, 1987, Statistics in medicine.

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.

Frazier, R. Huddart, T. Powles, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: Report from the Children's Oncology Group.

J. Cullen, J. Ross, J. Amatruda, 2014, Journal of pediatric surgery.

Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy

M. Sydes, S. Bielack, P. Hogendoorn, 2019, JMIR research protocols.

MAP plus maintenance pegylated interferon α-2b (MAPIfn) versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 "good response" randomization.

M. Sydes, R. Randall, M. Eriksson, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group

Helen X. Chen, L. Doyle, L. Wagner, 2015, Pediatric blood & cancer.

Phase IEvaluation of Oral and IntravenousVinorelbine in Pediatric Cancer Patients : AReport from the Children ’ s Oncology Group

J. Kuttesch, M. Krailo, W. Bleyer, 2006 .

Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval‐Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group

S. Ranganathan, J. D. Femino, R. Gorlick, 2016, Pediatric blood & cancer.

A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.

S. Baruchel, P. Adamson, A. Pappo, 2012, European journal of cancer.

Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study.

P. Adamson, M. Hogarty, M. Krailo, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group.

S. Lipshultz, M. Devidas, M. Bernstein, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Environmental exposure to residential pesticides, chemicals, dusts, fumes, and metals, and risk of childhood germ cell tumors.

X. Shu, L. Robison, S. Davies, 2006, International journal of hygiene and environmental health.

Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group

K. Matthay, S. Lessnick, E. Sinclair, 2016, Clinical Cancer Research.

Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

G. Ha, B. Crompton, K. Stegmaier, 2019, British Journal of Cancer.

A Decade in Banking Ewing Sarcoma: A Report from the Children’s Oncology Group

S. Phillips, S. Lessnick, G. Siegal, 2013, Front. Oncol..

A Phase I Study of 17-Allylaminogeldanamycin in Relapsed/Refractory Pediatric Patients with Solid Tumors: A Children's Oncology Group Study

R. Gilbertson, J. Neglia, P. Adamson, 2007, Clinical Cancer Research.

Impact of central surgical review in a study of malignant germ cell tumors.

C. Rodríguez-Galindo, A. L. Frazier, J. Cullen, 2015, Journal of pediatric surgery.

Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study

P. Adamson, M. Ames, R. Gorlick, 2013, Pediatric blood & cancer.

A randomized study comparing high-dose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group.

M. Krailo, C. Fryer, W. Bleyer, 1987, Medical and pediatric oncology.

Quality of life (QoL) in osteosarcoma: First results of the presurgery treatment period of EURAMOS-1 (NCT00134030).

M. Sydes, M. Bernstein, A. Wiener, 2010 .

Limitations of numerical ratios for defining monoclonality of immunoglobulin light chains in B-cell lymphomas.

J. Parker, M. Krailo, M. Samoszuk, 1985, Diagnostic immunology.

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

E. V. Van Allen, G. Ha, B. Crompton, 2018, British Journal of Cancer.

A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: A Children's Oncology Group study

G. Reaman, J. Reid, M. Ames, 2008, Pediatric blood & cancer.

The Children's Oncology Group Childhood Cancer Research Network (CCRN): Case catchment in the United States

P. Adamson, G. Reaman, J. Ross, 2014, Cancer.

Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence

J. Mora, D. Rakheja, L. Looijenga, 2019, Nature communications.

Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group

G. Vezina, A. Buxton, A. Gajjar, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin in childhood brain tumors: A children's cancer study group phase II trial

P. Gaynon, M. Krailo, L. Ettinger, 1990, Cancer.

Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children’s Oncology Group

J. Healey, R. Randall, M. Gebhardt, 2016, Annals of Surgical Oncology.

Vincristine/irinotecan/temsirolimus upfront window treatment of high‐risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee

C. Weldon, C. Rodríguez-Galindo, S. Ranganathan, 2023, Pediatric blood & cancer.

Study of 17-Allylaminogeldanamycin in Relapsed / Refractory Pediatric Patients with SolidTumors : AChildren ’ s Oncology Group Study

R. Gilbertson, J. Neglia, P. Adamson, 2007 .

Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International Consortium

A. L. Frazier, M. Krailo, M. Murray, 2023, Pediatric blood & cancer.

Efficacy of busulfan-melphalan high dose chemotherapy consolidation (BuMel) compared to conventional chemotherapy combined with lung irradiation in ewing sarcoma (ES) with primary lung metastases: Results of EURO-EWING 99-R2pulm randomized trial (EE99R2pul).

U. Dirksen, I. Judson, D. Hawkins, 2016 .

The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group.

M. Krailo, C. Fryer, W. Bleyer, 1988, Journal of pediatric surgery.

Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence

P. Leavey, Zhengjia Chen, M. Bernstein, 2007 .

Phase I Trial of Anti-B4-Blocked Ricin in Pediatric Patients With Leukemia and Lymphoma

G. Reaman, M. Krailo, P. Sondel, 2001, Journal of immunotherapy.

Assessment of extent of surgical resection of primary high‐grade osteosarcoma by treating institutions: A report from the Children's Oncology Group

R. Randall, M. Bernstein, L. Teot, 2016, Journal of surgical oncology.

The effects of dexrazoxane on cardiac status and second malignant neoplasms (SMN) in doxorubicin-treated patients with osteosarcoma (OS).

S. Lipshultz, M. Bernstein, K. Janeway, 2012 .

A single‐arm study of systemic and sub‐Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231)

C. Shields, J. O'Brien, D. Gombos, 2020, Pediatric blood & cancer.

A Phase I dose escalation of combination chemotherapy with granulocyte‐macrophage–colony stimulating factor in patients with neuroblastoma

K. Matthay, M. Krailo, Mark D. Krailo, 2000, Cancer.

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the childrens cancer group

P. Gaynon, S. Siegel, N. Ru, 1994 .

A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group.

K. Ruccione, N. Ru, W. Krivit, 1990, American Journal Of Pediatric Hematology/Oncology.

A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG

Ricardo J. Flores, C. Lau, T. Man, 2017, Cancer.

Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: A report of the children's oncology group (COG)

A. L. Frazier, M. Krailo, N. Marina, 2013, Pediatric blood & cancer.

Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children’s Oncology Group

Amanda E. Janitz, G. Tomlinson, G. Ramachandran, 2017, Journal of Exposure Science and Environmental Epidemiology.

Intensive multi-modality therapy for extra-ocular retinoblastoma (RB): A Children's Oncology Group (COG) trial (ARET0321).

T. Merchant, C. Rodríguez-Galindo, M. Chintagumpala, 2017 .

The Childrens Cancer Group (CCG) Studies

M. Krailo, J. Miser, 1993 .

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the childrens cancer group

P. Gaynon, S. Siegel, N. Ru, 1994, Cancer.

Children's Oncology Group's 2023 blueprint for research: Bone tumors

P. Grohar, K. Janeway, D. Reed, 2023, Pediatric blood & cancer.

Current surgical management of children with osteosarcoma and pulmonary metastatic disease: A survey of the American Pediatric Surgical Association.

M. Krailo, T. Lautz, R. Dasgupta, 2020, Journal of pediatric surgery.

The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma

Ricardo J. Flores, T. Man, C. McGee, 2017, Pediatric blood & cancer.

Lack of Significant Activity of 2'‐Deoxycoformycin Alone or in Combination with Adenine Arabinoside in Relapsed Childhood Acute Lymphoblastic Leukemia

G. Reaman, M. Krailo, J. Miser, 1992, American journal of clinical oncology.

Phase II trial of indicine N-oxide in relapsed pediatric solid tumors

D. Hammond, W. Krivit, M. Krailo, 1991, Investigational New Drugs.

Osimertinib plus necitumumab in EGFR-mutant NSCLC: Final results from an ETCTN California Cancer Consortium phase I study.

S. Groshen, C. Paweletz, H. Wakelee, 2022, Journal of Clinical Oncology.

K. S. Hall, M. Sydes, P. Leavey, 2016, The Lancet. Oncology.

Abstract 4352: Systemic levels of neuropeptide Y are elevated in Ewing's sarcoma patients

Donald A. Barkauskas, Haifa Mtaweh, J. Toretsky, 2011 .

Consensus classification of pediatric hepatocellular tumors: A report from the Children's Hepatic tumors International Collaboration (CHIC)

B. Morland, Yukichi Tanaka, R. Alaggio, 2023, Pediatric blood & cancer.

Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's oncology group trial, AHEP0731.

C. Weldon, C. Rodríguez-Galindo, G. Tiao, 2022, Journal of pediatric surgery.

A Phase I study of granulocyte‐macrophage‐colony stimulating factor/interleukin‐3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors

G. Reaman, M. Cairo, B. Blazar, 1998, Cancer.

Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent

J. Reid, A. Buxton, K. Janeway, 2020 .

Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group

R. Goldsby, K. Janeway, R. Gorlick, 2016, Pediatric blood & cancer.

Outcome of recurrent osteosarcoma patients enrolled in seven phase II trials through CCG, POG, and COG: Learning from the past to move forward.

D. Hawkins, B. Widemann, T. Zwerdling, 2015 .

Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031

J. Healey, P. Grohar, A. Buxton, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group Study.

B. Langholz, C. Rodríguez-Galindo, D. Albert, 2016, Ophthalmology.

Characterizing Lymphovascular Invasion in Pediatric and Adolescent Malignant Ovarian Nongerminomatous Germ Cell Tumors: A Report from the Children’s Oncology Group

Michelle M. Nuño, F. Hazard, A. L. Frazier, 2023, Journal of Pediatric Surgery.

Imaging Appearance Of Nongerminoma Pediatric Ovarian Germ Cell Tumors Does Not Discriminate Benign From Malignant Histology.

J. Ross, M. Krailo, D. Billmire, 2020, Journal of pediatric and adolescent gynecology.

Carboplatin (CBP) versus cisplatin (CP) within prognostic groups in pediatric extracranial malignant germ cell tumors (MGCTs).

C. Rodríguez-Galindo, A. L. Frazier, M. Krailo, 2012 .